{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-026086","form_type":"8-K","ticker":"KURA","cik":"0001422143","company_name":"Kura Oncology, Inc.","filed_at":"2023-06-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.799674+00:00","generated_at":"2026-06-14T08:06:22.398161+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Stockholders approve amendment increasing share reserve by 4.05M shares","bullets":["At May 31 annual meeting, stockholders approved Amended 2014 Plan increasing authorized shares by 4,050,000.","Diane Parks and Mary T. Szela elected as Class III directors until 2026 annual meeting.","Ernst & Young LLP ratified as independent auditor for fiscal year ending Dec 31, 2023.","Advisory vote on executive compensation approved with ~52M for vs ~0.88M against.","Amended 2014 Plan approved with ~46.8M for, ~5.9M against, ~1.4M abstain."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-026086","json":"https://secwatch.observer/filing/0000950170-23-026086.json","markdown":"https://secwatch.observer/filing/0000950170-23-026086.md","text":"https://secwatch.observer/filing/0000950170-23-026086.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1422143/000095017023026086/0000950170-23-026086-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1422143/000095017023026086/kura-20230531.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T08:06:22.398161+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"09d3061d4655d0d082b80afc226e9f99b65eda50","claim":"Kura Oncology, Inc. shareholders approved Election of Class III Directors at the 2023-05-31 meeting.","evidence_excerpt":"Name of Director Elected For Withheld Broker Non-Votes Diane Parks 39,370,803 14,742,373 1,860,281 Mary T. Szela 53,945,761 167,415 1,860,281","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017023026086/0000950170-23-026086-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-05-31"}],"fact_type":"shareholder_vote"},{"claim_id":"2221903ad66478f96e6f9ad577b3d81c8bb41811","claim":"Kura Oncology, Inc. shareholders approved Ratification of Appointment of Ernst & Young LLP as Independent Registered Public Accounting Firm at the 2023-05-31 meeting.","evidence_excerpt":"For Against Abstain Broker Non-Votes 55,916,556 34,565 22,336 —","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017023026086/0000950170-23-026086-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-05-31"}],"fact_type":"shareholder_vote"},{"claim_id":"eb373bf346088659dfae9405ef88d895535574a4","claim":"Kura Oncology, Inc. shareholders approved Approval of Amended 2014 Plan at the 2023-05-31 meeting.","evidence_excerpt":"For Against Abstain Broker Non-Votes 46,803,922 5,914,387 1,394,867 1,860,281","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017023026086/0000950170-23-026086-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-05-31"}],"fact_type":"shareholder_vote"},{"claim_id":"ef0483f6e641f2562ba24d328040d64cf9f9c3a8","claim":"Kura Oncology, Inc. shareholders approved Advisory Vote on Executive Compensation at the 2023-05-31 meeting.","evidence_excerpt":"For Against Abstain Broker Non-Votes 51,834,962 879,497 1,398,717 1,860,281","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017023026086/0000950170-23-026086-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-05-31"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}